News

CFAS II is the first multi-area study globally to have been designed and powered from its outset to compare prevalence and incidence, and test using as identical methods as possible, new ...
Dublin, Oct. 21, 2020 (GLOBE NEWSWIRE) -- The "Contrast Media - Global Market ... and Ultrasound supported by the prevalence of chronic diseases among the growing global population and the ensuing ...
The remaining 34 studies were considered for the systematic comparison between TNBC and non-TNBC for prevalence and clinical features at incidence, such as age, grade, and lymph node involvement. Fig ...